CV 1. Name: Şehsuvar Ertürk 2. Place and Date of Birth: Ankara, 14.02.1963 3. Institution: Ankara University School of Medicine 4. Field: Medicine/Nephrology

5. Area of Interest

a) Hypertension b) Ambulatory blood pressure monitoring c) Hemodialysis d) Renal anemia

6. Education:

a) Division of Renal Diseases and Hypertension, University of Minnesota Jun-Dec 1999 b) Department of Nephrology, Ankara University School of Medicine Apr 1996 c) Department of Medicine, Ankara University School of Medicine Nov 1992 d) Ankara University School of Medicine Jun 1985

7. Academic Positions: a) Prof. Apr 2003 b) Assoc. Prof. Dec 1997 c) Assist. Prof. May 1996

8. Positions Held:

a) Faculty, Dept. of Nephrology, Ankara University School of Medicine May 1996- b) Dean, Ankara University School of Medicine Nov 2012-Jul 2017 c) Director, Medical ICU, Ankara University School of Medicine Mar 2006-Jan 2007 d) Vice Medical Administrator, Ankara University School of Medicine, Ibni Sina Hospital Sep 2000-Feb 2007 e) International Fellow, ISN (International Society of Nephrology) Division of Renal Diseases and Hypertension, University of Minnesota Jun-Dec 1999 f) Fellow, Dept. of Nephrology, Ankara University School of Medicine Apr 1994-Apr 1996 g) Attending physician, Hemodialysis Unit, Dept. of Nephrology,

Ankara University School of Medicine Aug 1993-Apr 1994 h) Physician, Ministry of Health, Ankara Elmadağ State Hospital Feb 1993-Aug 1993 i) Resident, Dept. of Medicine, Ankara University School of Medicine May 1987-Nov 1992 j) Physician, Intensive Care Unit, Dept. of Anesthesiology and Reanimation,

Istanbul University Cerrahpaşa Medical School Sep 1985-May 1987

9. Awards a) TÜBİTAK Medical Research Award of Turkey 2004 b) TÜBİTAK encouragement Award 2003 c) Second Prize, ISN Fellows Posters. The ASN/ISN World Congress of Nephrology,

San Francisco, California, Oct 13-17, 2001 d) International Society of Nephrology, ISN Fellowship Training Award May 1999

10. Memberships

a) Turkish Medical Association b) Turkish Society of Nephrology c) Turkish Society of Hypertension and Renal Diseases d) Turkish Society of Internal Medicine e) European Renal Association-EDTA f) International Society of Nephrology g) American Society of Nephrology

11. Address

Şehsuvar Ertürk, M.D. Ankara University School of Medicine Department of Nephrology Ibni Sina Hospital Academic Campus M206 06100, Ankara, Turkey Tel: (312) 508 2168 – 508 2411 Fax: (312) 311 43 37 E-mail: erturk@medicine.ankara.edu.tr sehsuvarerturk@gmail.com

12. Publications (*)1. Is sublingual nifedipine administration superior to oral administration in the active treatment of hypertension? E. Diker, Ş. Ertürk, G. Akgün. Angiology 43: 477-481, 1992. (*)2. P-Glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols. M. Beksaç, H. Akan, H. Koç, O. İlhan, Ş. Ertürk, A. Güneyli, Y. İkizünal, O.S. Şardaş.

Medical Oncol Tumor Pharmacother 9: 101-105, 1992. (*)3. The clinical correlations of serum Tumor Necrosis Factor-Alpha in acute leukemias: A predictor of response and relapse?

M. Beksaç, Ş. Ertürk, H. Akan, H. Koç, O. İlhan. Leukemia 7: 1773-1776, 1993. (*)4. Amyloid deposition in the thyroid gland in patients with amyloidosis: An incidence study with fine-needle aspiration biopsy of the thyroid. Ş. Ertürk, N. Duman, K. Ateş, C. Ekinci, B. Erbay, O. Karatan, G. Erdoğan, E. Ertuğ, S. Dizbay Sak. Nephrol Dial Transplant 10: 1473, 1995. 5. Plasma terminal complement complex concentrations in renal allograft recipients. K. Ateş, M. Duranay, Ş. Ertürk, D. Aylı, B. Erbay, N. Duman, O. Karatan, E. Ertuğ. Nephron 72: 371, 1996. (*)6. Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors. Ş. Ertürk, K. Ateş, N. Duman, O. Karatan, B. Erbay, E. Ertuğ. Nephrol Dial Tranplant 11: 396-397, 1996. (*)7. Serum cytokine levels in uremic patients. Ş. Ertürk, K. Ateş, N. Duman, H. Tutkak, D. Aylı, O. Karatan, B. Erbay, E. Ertuğ. Nephron 72:492, 1996. (*)8. Comparison of aminophylline and insulin infusions in treatment of hyperkalemia in patients with end-stage renal disease. M. Duranay, K. Ateş, Ş. Ertürk, N. Duman, O. Karatan, B. Erbay, AE. Ertuğ. Nephron 73:105, 1996. (*)9. Renal amyloidosis complicating Takayasu’s arteritis: A case report. K. Ateş, Ş. Ertürk, E. Diker, O. Karatan, N. Duman, S. Dizbay Sak, B. Erbay, E. Ertuğ. Nephron 73:111-112, 1996. (*)10. A comparison between straight single-cuff and curled double-cuff catheters in patients on continuous ambulatory peritoneal dialysis. K. Ateş, O. Karatan, Ş. Ertürk, B. Erbay, N. Duman, G. Nergisoğlu, AE. Ertuğ. Nephrol Dial Transplant 11: 914, 1996. 11. Dialysate/Plasma ratio of which solute is better correlate with clinical outcome in continuous ambulatory peritoneal dialysis patients. K. Ateş, Ş. Ertürk, G. Nergisoğlu, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. Nephrol Dial Transplant 11: 1499-1500, 1996. (*)12. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Ş. Ertürk, AE. Ertuğ, K. Ateş, N. Duman, SM. Aslan, G. Nergisoğlu, E. Diker,

Ç. Erol, O. Karatan, B. Erbay. Nephrology Dialysis Transplantation 11: 2050-2054, 1996. (*)13. Evaluation of the methods used to determine dialysis adequacy in CAPD patients. K. Ateş, Ş. Ertürk, G. Nergisoğlu, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. Nephrol Dial Transplant 11: 2108-2109, 1996. (*)14. The sex dependent variations in peritoneal membrane transport properties in CAPD patients. K. Ateş, Ş. Ertürk, G. Nergisoğlu, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. Nephrol Dial Transplant 11: 2375-2376, 1996. (*)15. A comparison between percutaneous and surgical placement techniques of permanent peritoneal dialysis catheters. K. Ateş, Ş. Ertürk, O. Karatan, N. Duman, G. Nergisoğlu, D. Aylı, B. Erbay, AE. Ertuğ. Nephron 75: 98-99, 1997. 16. Hypertension and left ventricular hypertrophy in haemodialysis patients. Ş. Ertürk, AE. Ertuğ. J Hypertens 15: 327, 1997. (*)17. A case of Guillain-Barre syndrome complicated by nephrotic syndrome and p-ANCA positivity. K. Keven, G. Nergizoğlu, Ş. Ertürk, M. Kılıçkap, K. Ateş, H. Akar, B. Erbay, O. Karatan, N. Duman, AE. Ertuğ Nephron 80: 361-362, 1998 18. Long-term evolution of cardiomyopathy in dialysis patients. Ş. Ertürk. Kidney Int 56: 349, 1999. (*)19. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients. Ş. Ertürk, G. Nergizoglu, K. Ateş, B. Erbay, N. Duman, O. Karatan, AE. Ertuğ. Nephrol Dial Transplant 14: 1912-1916, 1999. (*)20. Carotid intima-media thickness and ACE-gene polymorphism in hemodialysis patients. G. Nergizoglu, K. Keven, M. A. Gürses, Ö. Aras, Ş. Ertürk, N. Duman, K. Ateş, H. Akar, N. Akar, O. Karatan, B. Erbay, AE. Ertuğ. J Nephrol 12: 261-265, 1999. (*)21. Tuberculosis of the skull in a patient on maintenance haemodialysis. G. Nergizoglu, N. Duman, Ş. Ertürk, K. Keven, K. Ateş, H. Akar, G. Bademci, Ç. Berk, S. Erekul, B. Erbay, O. Karatan, AE. Ertuğ. Nephrol Dial Transplant 14: 2019-2021, 1999.

22. Delivery of healthy infant during hemodialysis session. Ş. Ertürk, H. Akar, A. Üçkuyu, G. Nergizoglu, K. Keven, S. Bakkaloğlu, K. Ateş, N. Duman, J Nephrol 13: 75-77, 2000. (*)23. The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD Patients. K. Ateş, R. Koç, G. Nergizoğlu, Ş. Ertürk, K. Keven, A. Şen, O. Karatan. Peritoneal Dial Int 20: 220 - 226, 2000. (*)24. Remission of nephrotic syndrome after removal of localized Castleman's Disease. K. Keven, G. Nergizoglu, K. Ateş, S. Erekul, D. Orhan, Ş. Ertürk, Ö. Tulunay, O. Karatan, AE. Ertuğ. Am J Kidney Dis 35: 1207-1211, 2000. (*)25. ACE inhibitors and erythropoietin response in hemodialysis patients. Ş. Ertürk. Am J Kidney Dis 36: 880, 2000. (*)26. Renal amyloidosis in a patient with homozygous sickle cell anemia and M694V/M694V mutation. H. Akar, K. Keven, G. Nergizoglu, Ş. Ertürk, K. Ateş, B. Erbay, N. Akar, N. Duman, O. Karatan. Nephron 86: 383-384, 2000. (*)27. Hematopoietic cell transplantation-related nephropathy. M. Arat, Ö. Arslan, M. Beksaç, K. Keven, G. Nergizoğlu, Ş. Ertürk. Am J Kidney Dis 37: 218-219, 2001. (*)28. Effect of fluid and sodium removal on mortality in peritonel dialysis patients. K. Ateş, G. Nergizoğlu, K. Keven, A. Şen, S. Kutlay, Ş. Ertürk, N. Duman, O. Karatan, E. Ertuğ. Kidney Int 60: 767-776, 2001. (*)29. Peritoneal protein losses do not have a significant impact on nutritional status in CAPD patients. K. Ates, A. Oztemel, G. Nergizoglu, Ş. Ertürk, K. Keven, H. Akar, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. Perit Dial Int 21: 519-522, 2001. (*)30. Recognition of neurocognitive dysfunction in chronic hemodialysis patients. S. Kutlay, G. Nergizoglu, N. Duman, T. Atlı, K. Keven, Ş. Ertürk, K. Ates, O. Karatan. Ren Fail 23: 781-787, 2001. (*)31. A case of familial Mediterranean fever with amyloidosis as the first manifestation. S. Kutlay, E. Yılmaz, ES. Koytak, Ö. Tulunay, K. Keven, M. Özcan, Ş. Ertürk.

Am J Kidney Dis 38: E34, 2001. (*)32. Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever. K. Keven, E. Öztaş, H. Aksoy, N. Duman, B. Erbay, Ş. Ertürk. Am J Kidney Dis 38: E39, 2001. (*)33. Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. H. Akar, K. Keven, H. Çelebi, D. Orhan, G. Nergizoğlu, B. Erbay, Ö. Tulunay, M. Özcan, Ş. Ertürk. J Nephrol 15: 79-82, 2002. (*)34. Is vitamin D receptor gene polymorphism an independent predictor of mortality in hemodialysis patients? Ş. Ertürk, S. Kutlay, K. Keven. Am J Kidney Dis 39: 441-442, 2002. (*)35. Predictors of renal function following lung or heart-lung transplantation. A. Ishani, Ş. Ertürk, MI. Hertz, AJ Matas, K. Savik, ME. Rosenberg. Kidney Int 61: 2228-2234, 2002. (*)36. The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Ş. Ertürk, S. Kutlay, HG. Karabulut, K. Keven, G. Nergizoğlu, K. Ateş, I. Bökesoy, N. Duman. Am J Kidney Dis 40:816-823, 2002. (*)37. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus. K. Keven, H. Akar, S. Kutlay, G. Nergizoğlu, B. Erbay, Ş. Ertürk. J Nephrol 15: 720-723, 2002. (*)38. General or disease specific questionnaire? A comparative study in hemodialysis patients. S. Kutlay, G. Nergizoglu, Ş. Kutlay, et al. Renal Failure 25: 95-103, 2003. (*)39. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. K. Keven, S. Kutlay, G. Nergizoğlu, Ş. Ertürk.

Am J Kidney Dis 41: 1233-1239, 2003. (*)40. Vitamin C for hyporesponsiveness to EPO: A cure for all? Reply. Am J Kidney Dis 42:848-849, 2003. K. Keven, Ş. Ertürk. (*)41. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene

polymorphisms on development of amyloidosis in FMF patients. E. Yılmaz, B. Balcı, S. Kutlay, S. Özen, Ş. Ertürk, A. Öner, N. Beşbaş, A. Bakkaloğlu. Turkish J Pediatr 45: 198-202, 2003. (*)42. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. K. Keven, M. Şahin, S. Kutlay, Ş. Şengül, Ş. Ertürk, S. Ersöz, B. Erbay. Transpl Infect Dis 5: 181-186, 2003. (*)43. Tuberculous otitis media in a renal transplant recipient. İ. Ergün, K. Keven, Ş. Şengül, S. Kutlay, A. Sertçelik, Ş. Ertürk, B. Erbay.

Am J Kidney Dis 43: E1-E3, 2004. 44. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium. Ş. Şengül, K. Keven, S. Kutlay, İ. Ergün, A. Azap, Ş. Ertürk, B. Erbay. Am J Kidney Dis 44: A47, E47-49, 2004. (*)45. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: A single-center experience. K. Keven, Ş. Şengül, S. Kutlay, Y. Ekmekçi, E. Anadol, G. Nergizoğlu, K. Ateş, Ş. Ertürk, S. Ersöz, B. Erbay. Transplant Proc 36: 2632-2634, 2004.

46. Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients.

K. Keven, S. Kutlay, G. Nergizoğlu, Ş. Ertürk. Kidney Int 68:411, 2005. (*)47. Serum C-reactive protein level is associated with renal function and it affects echocardiographic cardiovascular disease in pre-dialysis patients.

K. Ateş, Ö. Yılmaz, S. Kutlay, A. Ateş, G. Nergizoğlu, Ş. Ertürk. Nephron Clin Pract 101:c190-c197, 2005. (*)48. Two sisters with familial Mediterranean fever: Lack of correlation between genotype and phenotype?

S. Kutlay, Ş. Sengul, K. Keven, Ş. Ertürk, B. Erbay. J Nephrol 19:104-107, 2006. (*)49. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. S. Kutlay, İ. Dinçer, Ş. Şengül, G. Nergizoğlu, N. Duman, Ş. Ertürk. Am J Kidney Dis 47:485-492, 2006. (*)50. Identification of patients at risk of acute rejection by pre- and posttransplantation monitoring of soluble CD30 levels in kidney transplantation. Ş. Şengül, K. Keven, Ü. Görmez, S. Kutlay, Ş. Ertürk, B. Erbay.

Transplantation 81:1216-1219, 2006. (*)51. Gene polymorphism association studies in dialysis: Bone and mineral metabolism. Ş. Ertürk, for the DialGene Consortium. Semin Dial 19:232-237, 2006. (*)52. The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. K. Keven, S. Yalçın, B. Canbakan, S. Kutlay, Ş. Şengül, Ş. Ertürk, B. Erbay. Transplant Proc 38: 1323-1326, 2006. (*)53. Thrombophilia and avascular necrosis of femoral head in kidney allograft recipients. Y. Ekmekçi, K. Keven, N. Akar, Y. Egin, Ş. Şengül, S. Kutlay, Ş. Ertürk, B. Erbay. Nephrol Dial Transplant 21: 3555-3558, 2006. (*)54. Acute cytomegalovirus infection complicated by venous thrombosis in a renal transplant recipient. Ş. Şengül, Y. Bozkuş, S. Kutlay, K. Keven, Ş. Ertürk, B. Erbay. Transplant Proc 38:3116-3117, 2006.

(*)55. Renal tubular acidosis after kidney transplantation: Incidence, risk factors and clinical implications. K. Keven, R. Özturk, Ş. Şengül, S. Kutlay, I. Ergün, Ş. Ertürk, B. Erbay. Nephrol Dial Transplant 22:906-910, 2007 (*)56. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. N. Türkçapar, T. Tuncalı, S. Kutlay, B.Y. Burhan, G. Kınıklı, Ş. Ertürk, M. Duman. Rheumatol Int 27:545-551, 2007 (*)57. Predictors of left ventricular hypertrophy in patients with chronic kidney disease. B. Aktaş Yılmaz, T. Mete, İ. Dinçer, S. Kutlay, Ş. Şengül, K. Keven, Ş. Ertürk. Renal Failure 29: 303-307, 2007 (*)58. Urinary tract infections following renal transplantation: a single-center experience. O.K. Memikoğlu, K. Keven, Ş. Şengül, Z. Soypaçacı, Ş. Ertürk, B. Erbay. Transplant Proc 39:3131-3134, 2007. (*)59. AA Amyloidosis Associated with Systemic Lupus Erythematosus: Impact on Clinical Course and Outcome. B. Aktaş Yılmaz, N. Düzgün, T. Mete, L. Yazıcıoğlu, M. Saykı, A. Ensari, Ş. Ertürk. Rheumatol Int 28:367-370, 2008. (*)60. Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index. K. Keven, R. Calayoglu, Ş. Şengül, İ. Dinçer, S. Kutlay, Ş. Ertürk,

B. Erbay, G. Nergizoğlu. Clin Transplant 22:360-365, 2008. (*)61. LDL oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with C cyclosporine/tacrolimus. F. Bakar, K. Keven, B. Doğru, F. Aktan, Ş. Ertürk, A. Tüzüner, B. Erbay, S. Nebioğlu. Transplant Proc 41:1630-1633, 2009. (*)62. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation. K. Keven, S. Elmacı, Ş. Şengül, N. Akar, Y. Eğin, V. Genc, Ş. Ertürk, B. Erbay. Int Urol Nephrol 42:1093-1098, 2010. (*)63. Tuberculosis of the breast in a hemodialysis patient. O. Yazıcı, P. Mescigil, İ. Kepenekçi, P. Celepli, Ş. Şengül, A. Azap, Ş. Ertürk. Int Urol Nephrol 43:241-244, 2011. (*)64. Use of Home Sphygmomanometers in Turkey: A Nationwide Survey. T. Akpolat, Y. Erdem, Ü. Derici, Ş. Ertürk, Ş. Çağlar, E. Hasanoğlu, O. Karatan, Ş. Sindel, Ç. Turgan. Hypertens Res 35:356-361, 2012. (*)65. Urinary Angiotensinogen Level Is Correlated with Proteinuria in Renal Transplant Recipients. Ş. Erdogmus, Ş. Şengul, S.Kocak, İ. Kurultak, ZK Çelebi, S.Kutlay, K.Keven, B. Erbay, Ş. Ertürk. Transplantation Proc 45: 935-939, 2013. (*)66. Effect of Daily Sodium Intake on Post-transplant Hypertension in Kidney Allograft Recipients. Z. Soypacaci, Ş. Şengul, EA. Yıldız, K. Keven, S. Kutlay, Ş. Ertürk, B.Erbay. Transplantation Proc 45: 940-943, 2013. 67. Constrictive Pericarditis After Renal Transplantation: Three Case Reports. ZK. Çelebi, K. Keven, Ş. Şengul, T. Sayın, L. Yazıcıoğlu, A. Tüzüner, Ş. Ertürk, N. Duman, B. Erbay. Transplantation Proc 45: 953-955, 2013. (*)68. Receptor-associated protein blocks internalization and cytotoxicity of myeloma light chain in cultured human proximal tubular cells. Ş. Sengul, Ş. Ertürk, AM. Khan, V. Batuman. PLoS One 23;8(7):e70276, 2013. (*)69. Controlling hypertension in Turkey: not a hopeless dream. Ş. Şengül, Y. Erdem, T. Akpolat, Ü. Derici, Ş. Sindel, O. Karatan, Ç. Turgan, E. Hasanoglu, Ş. Çağlar, Ş. Ertürk. Kidney Int Suppl 2013 Dec;3(4):326-331.

(*)70. Hypertension and chronic kidney disease in Turkey. Ş. Şengül, Y. Erdem, V. Batuman, Ş. Ertürk. Kidney Int Suppl 2013 Dec;3(4):308-311. 71. Fifteenth national congress of the Turkish Society of Hypertension and Renal Diseases. Ş. Şengül, Ş. Ertürk S, V. Batuman. Kidney Int Suppl 2013 Dec;3(4):307. (*)72. Urinary angiotensinogen, related factors and clinical implications in normotensive autosomal dominant polycystic kidney disease patients. İ. Kurultak, Ş. Şengül, S. Koçak, S. Erdoğmuş, R. Calayoğlu, P. Mescigil, K. Keven, Ş. Ertürk, B. Erbay, N. Duman. Ren Fail 36: 17-21, 2014. (*)73. Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment. ZK. Celebi, R. Calayoğlu, AK. Yalcı, S. Aktürk, Ş. Şengül, S. Kutlay, G. Nergizoğlu, Ş. Ertürk, N. Duman, K. Ates, K. Keven. Int Urol Nephrol 46:2357-2360, 2014. (*)74. Effects of Hemodialysis on Tei Index: Comparison between Flow Doppler and Tissue Doppler Imaging. DM Gerede, S. Turhan, CT Kaya, OU Ozcan, H. Goksuluk, VK Vurgun, İ. Dinçer, S. Kutlay, Ş. Ertürk Ş, Ç. Erol. Echocardiography 32:1520-1526, 2015. (*)75. Turkish hypertension consensus report. M. Arıcı, A. Birdane, K. Güler, BO. Yıldız, B. Altun, Ş. Ertürk, S. Aydoğdu, M. Özbakkaloğlu, HÖ. Ersöz, G. Süleymanlar, T. Tükek, L. Tokgözoğlu, Y. Erdem; Türk Kardiyoloji Derneği (TKD); Türk İç Hastalıkları Uzmanlık Derneği (TİHUD); Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD); Türk Nefroloji Derneği (TND); Türk Hipertansiyon ve Böbrek Hastalıkları Derneği (THBHD. Turk Kardiyol Dern Ars 43:402-409, 2015. (*)76. Changes in hypertension prevalence, awareness, treatment, and control rates in

Turkey from 2003 to 2012. Ş. Şengül, T. Akpolat, Y. Erdem, Ü. Derici, M. Arıcı, Ş. Sindel, O. Karatan, Ç. Turgan, E. Hasanoğlu, Ş. Çaglar, Ş. Ertürk, Turkish Society of Hypertension and Renal Diseases. J Hypertension 34:1208-1217, 2016. (*)77. Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis. Z. Kendi Celebi, S. Kiremitçi, B. Özturk, S. Aktürk, Ş. Erdoğmuş, N. Duman, K. Ateş, Ş. Ertürk, G. Nergizoğlu, S. Kutlay, Ş. Şengül, A. Ensari, K. Keven. Amyloid 24:176-182, 2017.

(*)78. Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients. N. Casadevall, V. Dobronravov, KU. Eckardt, Ş. Ertürk, L. Martynyuk L, S. Schmitt, G. Schaffar, A. Rudy, A. Krendyukov, M. Ode. Clin Nephrol 88:190-197, 2017. 79. Dietary Sources of High Sodium Intake in Turkey: SALTURK II. Y. Erdem, T. Akpolat, Ü. Derici, Ş. Şengül, Ş. Ertürk, Ş. Ulusoy, B. Altun, M. Arıcı. Nutrients 24: E933, 2017. (*)80. Effect of unilateral nephrectomy on urinary angiotensinogen levels in living kidney donors: 1 year follow-up study. Z. Kendi Çelebi, A. Peker, S. Kutlay, S. Kocak, A. Tüzüner, Ş. Ertürk, K. Keven, Ş. Şengül. J Renin Angiotensin Aldosterone Syst 18:1470320317734082, 2017. (*)81. Non-diabetic kidney disease in type 2 diabetic patients: Prevalence, clinical predictors and outcomes. Ş. Erdoğmuş, S. Kiremitçi, Z. Kendi Çelebi, S. Aktürk, N. Duman, K. Ates, Ş. Ertürk, G. Nergizoğlu, S. Kutlay, Ş. Şengül, A. Ensari, K. Keven. Kidney Blood Pressure Res 42:886-893, 2017.

(*)82. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. Y. Erdem, G. Özkan, Ş. Ulusoy, M. Arıcı.Ü. Derici, Ş. Şengül, Ş. Sindel, Ş. Ertürk, Turkish Society of Hypertension and Renal Diseases. J Am Soc Hypertens 12:42-49, 2018. (*)83. Home sphygmomanometers can help in the control of blood pressure: a nationwide field survey. T. Akpolat, M. Arıcı, Ş. Şengül, Ü. Derici, Ş. Ulusoy, Ş. Ertürk, Y. Erdem. Hypertens Res 41:460-468, 2018. 84. Is sclerostin level associated with cardiovascular diseases in hemodialysis patients? G. Kundakci Gelir, Ş. Şengül, G. Nergizoglu, Ş. Ertürk, N. Duman, S. Kutlay. Blood Purif 46:118-125, 2018. 85. Clinical Correlates of Ambulatory Blood Pressure Phenotypes at a Tertiary Care Hospital in Turkey. Ş. Erdoğmuş, S. Kutlay, ZK Çelebi, T. Aydın, D. Örs Şendoğan, G. Kumru, K. Keven, G. Nergizoğlu, Ş. Ertürk, Ş. Şengül. Kidney Blood Press Res 43:690-700, 2018. 86. Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience.

Ş. Erdoğmuş, Z Kendi Çelebi, S. Aktürk, G. Kumru, N. Duman, K. Ateş, Ş. Ertürk, G. Nergizoğlu, S. Kutlay, Ş. Şengül, K. Keven. Amyloid 25:115-119, 2018. (*): Cited publications Meeting Abstracts 1. Clinical effects of ciclosporin A containing chemotherapy protocols in refractory hematological neoplasms. O. S. Şardaş, M. Beksaç, O. İlhan, H. Koç, H. Akan, G. Gürman, Ş. Ertürk, A. Güneyli. XIth Meeting of the International Society of Haematology European and African Division, August 31-September 6, 1991, Basel, Switzerland. Schweiz Med Wschr

121 (Suppl 43): 141, 1991. 2. The clinical correlations of serum Tumor Necrosis Factor-Alpha in acute leukemias: A predictor of response and relapse? M. Beksaç, Ş. Ertürk, H. Akan, H. Koç, O. İlhan, O.S. Şardaş. 24th Congress of the International Society of Haematology, 23-27 August 1992, London, UK. Abstracts: 340. 3. Ambulatory blood pressure monitoring in haemodialysis patients. Ş. Ertürk, A.E. Ertuğ, K. Ateş, N. Duman, S.M. Aslan, G. Nergisoğlu, E. Diker, Ç. Erol, O. Karatan, B. Erbay. XXXIIIrd Congress of The European Dialysis and Transplantation Association- European Renal Association, June 18-21, 1996, Amsterdam. Abstracts: 93. 4. The effect of peritoneal transport properties on clinical outcome in CAPD patients. K. Ateş, Ş. Ertürk, G. Nergisoğlu, O. Karatan, N. Duman, B. Erbay, A.E. Ertuğ. XXXIIIrd Congress of The European Dialysis and Transplantation Association- European Renal Association, June 18-21, 1996, Amsterdam. Abstracts: 331. 5. The limitations of Kt/Vurea and NPCR calculations in CAPD patients. K. Ateş, Ş. Ertürk, G. Nergisoğlu, O. Karatan, N. Duman, B. Erbay, A.E. Ertuğ. XXXIIIrd Congress of The European Dialysis and Transplantation Association- European Renal Association, June 18-21, 1996, Amsterdam. Abstracts: 332. 6. Effects of L-carnitine treatment on muscle functions in hemodialysis patients. B. Akdeniz, N. Duman, A. Ergün Ertuğ, G. Nergizoğlu, Ş. Ertürk, K. Ateş. XXXIII International Congress of Physiological Sciences, June 30-July 5, 1997, St. Petersburg: P024.02. 7. Cardiovascular and metabolic effects of exercise training in haemodialysis patients.

G. Nergizoğlu, A. Ergün Ertuğ, N. Duman, K. Keven, H. Akar, Ş. Ertürk, K. Ateş, O. Karatan, B. Erbay. XXXV. Congress of The European Renal Association-European Dialysis and Transplantation

Association, June 6-9, 1998, Rimini, Italy. Abstracts, p 257. 8. Carotid intima-media thickness in haemodialysis patients. G. Nergizoğlu, A. Ergün Ertuğ, N. Duman, K. Keven, H. Akar, Ş. Ertürk, K. Ateş, O. Karatan, B. Erbay. XXXV. Congress of The European Renal Association-European Dialysis and Transplantation

Association, June 6-9, 1998, Rimini, Italy. Abstracts, p 258. 9. Comparing different PNA or PCR calculation methods in CAPD patients. K. Ateş, A. Öztemel, G. Nergizoğlu, Ş. Ertürk, H. Akar, K. Keven, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. XXXV. Congress of The European Renal Association-European Dialysis and Transplantation

Association, June 6-9, 1998, Rimini, Italy. Abstracts, p 315. 10. The effect of peritoneal protein loss on nutritional status in CAPD patients. K. Ateş, A. Öztemel, G. Nergizoğlu, Ş. Ertürk, K. Keven, O. Karatan, H. Akar, N. Duman, B. Erbay, AE. Ertuğ. 19th Annual Conference on Peritoneal Dialysis, February 28-March 2, 1999, Charlotte, North

Carolina. Perit Dial Int 19(Suppl 1): S13, 1999. 11. The factors affecting peritonitis rate in CAPD patients. G. Nergizoğlu, K. Ateş, Ş. Ertürk, H. Akar, K. Keven, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. 19th Annual Conference on Peritoneal Dialysis, February 28-March 2, 1999, Charlotte, North

Carolina. Perit Dial Int 19(Suppl 1): S35, 1999. 12. The factors affecting peritoneal transport properties in CAPD patients. G. Nergizoğlu, K. Ateş, Ş. Ertürk, K. Keven, H. Akar, A. Şen, O. Karatan, N. Duman, B. Erbay, AE. Ertuğ. XXXVI. Congress of The European Renal Association-European Dialysis and Transplantation

Association, September 5-8, 1999, Madrid, Spain. Abstracts, p 329. 13. EPO responsiveness after withdrawing of the ACE inhibitors in haemodialysis patients. Ş. Ertürk, G. Nergizoğlu, K. Ateş, N. Duman, B. Erbay, O. Karatan, A. E. Ertuğ. XXXVI. Congress of The European Renal Association-European Dialysis and Transplantation

Association, September 5-8, 1999, Madrid, Spain. Abstracts, p 342. 14. Renal function following lung or heart/lung transplantation.

Ş. Ertürk, M. Hertz, C. Swanson, K. Savik, A. Ishani, M. Rosenberg. Transplant 2000: The first joint Annual Meeting of the ASTS and the AST, May 13-17, 2000, Chicago, Illinois; Transplantation 69: S232, 2000. 15. Renal transplantation for end-stage renal disease following lung or heart/lung transplantation.

Ş. Ertürk, M. Hertz, A. Matas, K. Savik, A. Ishani, M. Rosenberg.

Transplant 2000: The first joint Annual Meeting of the ASTS and the AST, May 13-17, 2000, Chicago, Illinois; Transplantation 69: S234, 2000. 16. The effect of fluid and sodium removal on blood pressure in peritoneal dialysis patients. G. Nergizoğlu, K. Ateş, Ş. Ertürk, K. Keven, O. Karatan, AE. Ertuğ. Tenth European Meeting on Hypertension, May 29-June 3, 2000, Göteborg, Sweden, Abstracts: S99. 17. The relationship of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms to echocardiographic findings in patients with renal amyloidosis. H. Akar, H.G. Karabulut, İ. Dinçer, Ş. Ertürk, G. Nergizoğlu, K. Keven, K. Ateş, A. Elhan, I. Bökesoy, A. E. Ertuğ. XXXVII. Congress of The European Renal Association-European Dialysis and Transplantation Association, September 17-20, 2000, Nice, France. Abstracts, p 187. 18. Plasma leptin levels and response to erytropoietin in haemodialysis patients. Ş. Ertürk, G. Nergizoğlu, S. Kutlay, K. Keven, K. Ateş, N. Duman, A. E. Ertuğ. XXXVII. Congress of The European Renal Association-European Dialysis and Transplantation Association, September 17-20, 2000, Nice, France. Abstracts, p 238. 19. The effects of L-carnitine supplementation on serum leptin level and boy fat mass in haemodialysis patients. G. Nergizoğlu, B. Akdeniz, N. Duman, H. Akar, K. Keven, Ş. Ertürk, K. Ateş, O. Karatan, B. Erbay, A. E. Ertuğ. XXXVII. Congress of The European Renal Association-European Dialysis and Transplantation Association, September 17-20, 2000, Nice, France. Abstracts, p 258. 20. The use of new heparin coated polycarbonate/urethane graft in secondary vascular accsess. A prospective trial. MA. Yerdel, S. Hazinedaroğlu, G. Nergizoğlu, M. Turan, S. Kutlay, Ş. Ertürk, K. Ateş, N. Duman. XXXVII. Congress of The European Renal Association-European Dialysis and Transplantation Association, September 17-20, 2000, Nice, France. Abstracts, p 276. 21. Predicting renal outcome following lung or heart/lung transplantation. Ş. Ertürk, A. Ishani, M. Hertz, C. Swanson, K. Savik, ME. Rosenberg. The ASN 33rd Annual Meeting and 2000 Renal Week, October 10-16, 2000, Toronto, Ontario, Canada. J Am Soc Nephrol 11: 716A-717A, 2000. 22. Avoidance of cyclosporine in the immediate post-transplant period in living-related

donor kidney transplants. Ş. Ertürk, Z. Baykal, K. Keven, S. Ersöz, G. Nergizoğlu, K. Ateş, E. Anadol, B. Erbay. XXXVIII. Congress of The European Renal Association-European Dialysis and Transplantation Association, June 24-27, 2001, Vienna, Austria. Nephrol Dial Transplant 16: A211, 2001.

23. Relationship between vitamin D receptor genotype and avascular necrosis in kidney transplant patiens. Y. Ekmekçi, B. Erbay, H.G. Karabulut, K. Ateş, I. Bökesoy, Ş. Ertürk. XXXVIII. Congress of The European Renal Association-European Dialysis and Transplantation Association, June 24-27, 2001, Vienna, Austria. Nephrol Dial Transplant 16: A231, 2001. 24. The effect of vitamin C on erythropoietin response in hemodialysis patients. K. Keven, S. Kutlay, G. Nergizoğlu, Ş. Ertürk. The 2001 ASN/ISN World Congress of Nephrology, October 10-17, 2001, San Francisco, California, USA. J Am Soc Nephrol 12: 357A-358A, 2001. 25. Impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Ş. Ertürk, S. Kutlay, H.G. Karabulut, K. Keven, G. Nergizoğlu, K. Ateş, I. Bökesoy, N. Duman. The 2001 ASN/ISN World Congress of Nephrology, October 10-17, 2001, San Francisco, California, USA. J Am Soc Nephrol 12: 764A, 2001. 26. The effect of intravenous vitamin C on erythropoietin response in haemodialysis

patients. K. Keven, S. Kutlay, G. Nergizoğlu, N. Duman, Ş. Ertürk. XXXIX. Congress of the European Renal Association-European Dialysis and Transplantation Association, July 14-17, 2002, Copenhagen, Denmark. Nephrol Dial Transplant 17 (Suppl 1): 229, 2002. 27. Renal transplantation following lung and heart-lung tansplantation. T. Kaneko, A. Ishani, Ş. Ertürk, M. Hertz, A. Matas, K. Savik, M. Rosenberg. American Transplant Congress 2003. Am J Transplant 3 (suppl 5):290, 2003. 28. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. K. Keven, M. Şahin, S. Kutlay, Ş. Şengül, S. Ersöz, Ş. Ertürk, B. Erbay. The ASN 36th Annual Meeting and Renal Week, November 12-17, 2003, San Diego, USA. 29. Oxidative stress and anti-oxidant defense system in kidney transplant patients. C. Hamamcıoğlu, K. Keven, Ş. Ertürk, B. Erbay, S. Nebioğlu. XLI ERA-EDTA CONGRESS, May 2004, Lisbon, Portugal. 30. The course and predictors of cardiac hypertrophy in patients with chronic kidney disease. B. Aktaş-Yılmaz, İ. Dinçer, S. Kutlay, Ş. Şengul, K. Keven, Ş. Ertürk. XLII ERA-European Dialysis and Transplant Association Congress. June 4-7, 2005, Istanbul, Turkey. 31. The presence of recipienst-derived renal cells in damaged allograft kidneys. T. Mete, A. Ensari, Ş. Şengül, K. Keven, B. Erbay, Ş. Ertürk.

XLII ERA-European Dialysis and Transplant Association Congress. June 4-7, 2005, Istanbul, Turkey. 32. Ambulatory monitoring versus pre-dialysis measurement of blood pressure for the prediction of left ventricular mass index in hemodialysis patients. S. Kutlay, Ş. Şengul, Y. Ekmekçi, İ. Dincer, G. Nergizoğlu, Ş. Ertürk. XLII ERA-European Dialysis and Transplant Association Congress. June 4-7, 2005, Istanbul, Turkey. 33. The contribution of genotypes at the MICA Gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. N. Turkcapar, T. Tuncalı, S. Kutlay, B. Burhan, Ş. Ertürk, G. Kınıklı, M. Duman. XLII ERA-European Dialysis and Transplant Association Congress. June 4-7, 2005, Istanbul, Turkey. 34. Daily sodium intake reflected by urinary sodium excretion and post-transplant hypertension in kidney allograft recipients. K. Keven, S. Yalçın, B. Canbakan, Ş. Ertürk, B. Erbay. 12th European Solid Organ Transplantation Congress, October 15-19, 2005, Geneva, Switzerland. 35. Determinants of arterial stiffness and carotid intima-media thickness in renal transplant patients. İ. Ergün, K. Keven, H. Özcan, Y. Ekmekçi, Ş. Şengül, G. Nergizoğlu, Ş. Ertürk, B. Erbay. XLIII ERA-EDTA CONGRESS, July 15-18, 2006 - Glasgow, United Kingdom: July 2006; Vol. 21, No. suppl_4 36. Renal tubular acidosis after kidney transplantation: Incidence, risk factors, and implications. K. Keven, R. Öztürk, Ş. Şengül, İ. Ergün, S. Kutlay, Ş. Ertürk, B. Erbay. XLIII ERA-EDTA CONGRESS, July 15-18, 2006 - Glasgow, United Kingdom: July 2006; Vol. 21, No. suppl_4 37. Thrombophilia and avascular necrosis in kidney allograft recipients. Y. Ekmekçi, K. Keven, N. Akar, Y. Egin, Ş. Şengül, S. Kutlay, Ş. Ertürk, B. Erbay. XLIII ERA-EDTA CONGRESS, July 15-18, 2006 - Glasgow, United Kingdom: July 2006; Vol. 21, No. suppl_4 38. Endothelial nitric oxide synthase gene GLU298ASP polymorphism does not predict arterial stiffness in renal transplant patients. İ. Ergün, K. Keven, H. Karabulut, B. Canbakan, S. Kutlay, Ş. Ertürk, O. Karatan, B. Erbay. XLIII ERA-EDTA CONGRESS, July 15-18, 2006 - Glasgow, United Kingdom: July 2006; Vol. 21, No. suppl_4

39. Oxidative stress and susceptibility of LDL to oxidation in renal transplant recipients. F. Bakar, AC Akbasli, F. Aktan, K. Keven, Ş. Ertürk, A. Tüzüner, B. Erbay, S. Nebioglu. FEBS JOURNAL 273: 160-160 Suppl. 1, JUN 2006 40. Effect of preload on new ejection phase index: IVA. S. Turhan, İ. Dinçer, S. Kutlay, Ç. Özdöl, M. Kılıçkap, T. Altın, Ş. Ertürk, Ç. Erol. World Congress of Cardiology 2006. 41. The effect of renal transplantation on arterial stiffness in patients with end-stage renal disease.

R. Calayoglu, K. Keven, Ş. Şengül, İ. Dinçer, S. Kutlay, G. Nergizoğlu, Ş. Ertürk, B. Erbay. ASN's 39th Annual Renal Week Meeting, San Diego, California, USA. 42. The value of serum osmolality measurements for the evaluation of volume status in hemodialysis patients. Ş. Ertürk, Ş. Şengül, İ. Dinçer, S. Kutlay, K. Keven, G. Nergizoğlu, N. Duman, O. Karatan, B. Erbay, K. Ateş. ASN's 39th Annual Renal Week Meeting, San Diego, California, USA. 43. The effect of renal transplantation on arterial stiffness and left ventricular hyperthrophy

in patients with end-stage renal disease.

R. Calayoglu, K. Keven, Ş. Şengül, İ. Dinçer, S. Kutlay, G. Nergizoğlu, K. Ateş, Ş. Ertürk, N. Duman, O. Karatan, B. Erbay. 44. Congress of the ERA-EDTA, June 21-24, 2007, Barcelona, Spain, FP480. 44. The effect of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Z. Soypaçacı, Ş. Şengül, K. Keven, S. Hazinedaroğlu, Ş. Ertürk, B. Erbay. ASN's 40th Annual Renal Week Meeting, San Diego, California, USA, 2007 [SA-PO451]. 45. Correlates of arterial wave reflection and arterial stiffness in hemodialysis patients. H. Keleş, S. Turhan, S. Kutlay, Ş. Şengül, K. Keven, G. Nergizoğlu, Ş. Ertürk, O. Karatan. 45. Congress of the ERA-EDTA, May 10-13, 2008, Stockholm, Sweden, SP108. 46. Inhibitory effect of receptor-associated protein on myeloma light-chain induced cytokine release in cultured human proximal tubular cells. Ş. Şengül, Ş. Ertürk, V. Batuman. 45. Congress of the ERA-EDTA, May 10-13, 2008, Stockholm, Sweden, MP112. 47. The effect of dietary salt intake on blood pressure in kidney transplant recipients. Z. Soypaçacı, Ş. Şengül, E. Akal Yıldız, S. Kutlay, Ş. Ertürk, B. Erbay, K. Keven. 45. Congress of the ERA-EDTA, May 10-13, 2008, Stockholm, Sweden, MP482.

48. Effect of receptor-associated protein on endocytosis and toxicity of myeloma light chain in cultured human proximal tubular cells. Ş. Şengül, M. Li, Ş. Ertürk, V. Batuman. ASN's 41st Annual Renal Week Meeting, November 4-9, 2008, Philadelphia, PA, USA, [TH-PO322]. 49. Plasma levels of soluble endothelial cell protein C receptor, soluble thrombomodulin and tumor necrosis factor in renal transplant recipients and hemodialysis patients:

Prospective comparative study. K. Keven, S. Elmacı, Ş. Şengül, N. Akar, Y. Eğin, Ş. Ertürk, B. Erbay. Conference: 8th American Transplant Congress, May 31-Jun 4, 2008, Toronto, Canada. AMERICAN JOURNAL OF TRANSPLANTATION Volume: 8 Supplement: 2 Pages: 597-597 Published: MAY 2008 50. OPTIMAL TREATMENT IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY: COMPARISON OF INTERMITTANT HEMOFILTRATION AND HEMODIALYSIS IN A RANDOMIZED CONTROLLED TRIAL S. Kutlay, İ. Kurultak, G. Nergizoglu, Ş. Ertürk, O. Karatan. Conference: 50th European-Renal-Association - European-Dialysis-and-Transplant- Association Congress, May 18-21, 20013, Istanbul, Turkey. NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 28 Supplement: 1 Pages: 331-331 Published: MAY 2013 51. PREVALENCE OF CMV INFECTION/DISEASE IN PATIENTS WITH GLOMERULAR DISEASE TREATED BY IMMUNOSUPPRESSIVE TREATMENT Z. Kendi Çelebi, R. Calayoglu, K. Keven, İ. Kurultak, P. Mescigil, B. Erbay, O. Karatan, N. Duman, Ş. Ertürk, G. Nergizoğlu, S. Kutlay, Ş. Şengül, K. Ateş. Conference: 50th European-Renal-Association - European-Dialysis-and-Transplant- Association Congress, May 18-21, 20013, Istanbul, Turkey. NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 28 Supplement: 1 Pages: 393-393 Published: MAY 2013 52. FACTORS ASSOCIATED WITH ANNUAL CHANGE IN PULSE WAVE VELOCITY IN DIALYSIS PATIENTS: RESULTS OF 1 YEAR FOLLOW-UP Z. Kendi Çelebi. S. Kutlay, Ş. Şengül, G. Nergizoglu, Ş. Ertürk, K. Ateş. Conference: 51st Congress of the European-Renal-Association(ERA)/European-Dialysis- and-Transplant-Association (EDTA), May 31-Jun 3, 2014, Amsterdam, NETHERLANDS NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 29 Supplement: 3 Pages: 240-240 Meeting Abstract: SP505 Published: MAY 2014 53. Does body mass index (BMI) modulate effect of dietary sodium reduction on blood pressure: a cross-over randomized trial. Erdem Y, Arıcı M, Altun B, Derici Ü, Şengül Ş, Ertürk Ş, Turgan Ç. Journal of the American Society of Hypertension 9(4):e53 · April 2015 DOI: 10.1016/j.jash.2015.03.121

54. SECONDARY AMYLOIDOSIS WITH RENAL INVOLVEMENT AND HISTOPATHOLOGIC CORRELATION. LONG TERM FOLLOW-UP RESULTS Celebi, Zeynep Kendi; Kiremitci, Saba; Ozturk, Bengi; et al. Conference: 52nd Congress of the European-Renal-Association-European-Dialysis-and- Transplant-Assocation Location: London, ENGLAND Date: MAY 28-31, 2015

NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 30 Supplement: 3 Meeting Abstract: SP114 Published: MAY 2015 55. CLINICAL OUTCOME OF ACUTE REJECTION EPISODES IN KIDNEY RECIPIENTS: ANALYSIS OF 12 YEARS OF SINGLE CENTER EXPERIENCE Akturk, Serkan; Kumru, Gizem; Celebi, Zeynep Kendi; Siyar Erdogmus; Acar Tuzuner; Sehsuvar Erturk; Sule Sengul; Kenan Keven Conference: 52nd Congress of the European-Renal-Association-European-Dialysis-and- Transplant-Assocation Location: London, ENGLAND Date: MAY 28-31, 2015

NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 30 Supplement: 3 Meeting Abstract: SP845 Published: MAY 2015 56. EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD Casadevall, Nicole; Dobronravov, Vladimir; Eckardt, Kai-Uwe; Ertürk, Ş; et al. Conference: 53rd ERA-EDTA Congress Location: Vienna, AUSTRIA Date: MAY 21-24, 2016

NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 31 Supplement: 1 Pages: 194-194 Meeting Abstract: SP312 Published: MAY 2016 57. RENAL AA AMYLOIDOSIS IN ELDERLY PATIENTS: CLINICAL MANIFESTATIONS, ETIOLOGIES AND OUTCOMES Siyar Erdogmus Gizem Kumru Sim Kutlay Sule Sengul Gokhan Nergizoglu Sehsuvar Erturk Kenan Ates Neval Duman Kenan Keven Nephrology Dialysis Transplantation, Volume 32, Issue suppl_3, 1 May 2017, Pages iii486,https://doi.org/10.1093/ndt/gfx164.MP155 Published: MAY 2017 58. NON-DIABETIC RENAL DISEASE IN TYPE 2 DIABETIC PATIENTS: PREVALENCE, CLINICAL

PREDICTORS AND OUTCOMES Siyar Erdogmus Zeynep Kendi Celebi Serkan Akturk Gizem Kumru Sim Kutlay Sule

Sengul Gokhan Nergizoglu Sehsuvar Erturk Kenan Ates Neval Duman Kenan Keven Nephrology Dialysis Transplantation, Volume 32, Issue suppl_3, 1 May 2017, Pages iii275–

iii276, https://doi.org/10.1093/ndt/gfx149.SP454 Published: MAY 2017 59. EFFECT OF UNILATERAL NEPRECHTOMY ON URINARY ANGIOTENSINOGEN LEVELS IN

LIVING KIDNEY DONORS: 1 YEAR FOLLOW UP STUDY Zeynep Kendi Celebi Ahmet Peker Sim Kutlay Senem Kocak Acar Tuzuner Sehsuvar

Erturk Kenan Keven Sule Sengul Nephrology Dialysis Transplantation, Volume 32, Issue suppl_3, 1 May 2017, Pages

iii380,https://doi.org/10.1093/ndt/gfx156.SP717 Published: MAY 2017